At Acenxion Biosystems, we agree with Dr. Doern. Antimicrobial susceptibility testing is the process of determining which antibiotic will be effective for an infection. Without it, all a doctor can prescribe is a broad-spectrum antibiotic and in many cases those will not work.
Our scalable, automated AST system seamlessly fits into current clinical workflow and reduces the time required for phenotypic AST results from days to just hours allowing clinicians rapid use of a targeted treatment thereby minimizing antibiotic exposure and limiting Anti-Microbial Resistance (AMR).
Current gold-standard phenotypic Antimicrobial Susceptibility Testing (AST) results are extremely labor intensive and notoriously slow. While doctors wait for test results, antibiotic resistance develops, hospital bills increase, patients suffer — or the results are too late and the patient dies. Acenxion's diagnostic technology can change that.
Skipping AST leads to poor antibiotic stewardship through excessive use of broad spectrum therapies or ineffective antibiotic prescriptions. This results in the spread of antibiotic resistance and harms everyone who might benefit from antibiotics in the future.
From the fluorescent microscope to penicillin-infused paper strips, many innovations in clinical diagnostics are the fusion of newly-discovered pathogen attributes with novel technology. The same is true at Acenxion Biosystems where we are delivering accurate results that are fast enough to make a difference.
Phenotypic AST results in 4-6 hours means each patient can receive a targeted treatment with demonstrated effectiveness. It also means those microbes are eliminated quickly mitigating AMR risks and extending the service life of antibiotics for everyone's benefit.
Acenxion Biosystems, Inc. All rights reserved. © 2024
Website design and development by Pixel Jam Digital